Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
High-quality evidence for the treatment of very rare diseases: IQWiG is involved in the EU project RealiseD Developing clinical trials to provide good evidence for very rare diseases, so that ...
The University of Manchester is bringing together some of the UK's brightest minds from across academia, industry and ...
While the European Medicines Agency (EMA ... The Regulation on Health Technology Assessment (HTAR), passed in 2021 under the auspices of European Network for Health Technology Assessment (EUnetHTA ...
In its first meeting of 2025, the European Medicines Agency ... EMA’s accelerated assessment program because it is considered to be of major public health interest, the agency said in a press ...
The regulatory frameworks in the life sciences and healthcare sector keep evolving rapidly and dynamically. Several important legislative reforms ...
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...
The final appraisal document from health technology assessment (HTA ... after Brukinsa was approved by the Medicines and Healthcare products Regulatory Agency (MHRA). That approval also included ...
On his first day in office, President Donald Trump signed an executive order withdrawing the U.S. from the World Health Organization ... the FDA and EMA [European Medicines Agency], they wanted ...
Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment.Troriluzole demonstrated a 50-70% slowing of SCA disease progression on the ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 33 tables and 60 figures, this 119-page report Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results